Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Contineum Therapeutics, Inc. Class A Common Stock
CTNMCurrent price
18.15 USD
-0.64 USD (-3.41%)
Last closed
18.73 USD
Company
www.contineum-tx.com
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
493 115 648 USD
Yield for 12 month
+13.44 %
1Y
3Y
5Y
10Y
15Y
CTNM
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. Its lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and progressive multiple sclerosis (MS). The company also develops PIPE-307, a novel, small molecule selective inhibitor of the muscarinic type 1 M1 receptor to treat depression and relapse remitting MS; and CTX-343, a peripherally-restricted LPA1R antagonist. Contineum Therapeutics, Inc. was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. The company was incorporated in 2009 and is headquartered in San Diego, California. Address: 10578 Science Center Drive, San Diego, CA, United States, 92121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
28.67 USDP/E ratio
–Dividend Yield
–Current Year
+50 000 000 USD
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
+49 805 000 USD
Last Year
-329 000 USD
Current Quarter
–
Last Quarter
-60 000 USD
Key Figures CTNM
1 year
3 years
5 years
10 years
EBITDA
-38 418 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
–
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
28.67 USD
Revenue TTM
–
Book Value
8.46 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.01 USD
Diluted Eps TTM
-0.01 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CTNM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CTNM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CTNM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
8.2516
Price Sales TTM
–
Enterprise Value EBITDA
20.7576
Price Book MRQ
2.2672
Financials CTNM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CTNM
For 52 weeks
13.27 USD
22 USD
50 Day MA
19.14 USD
Shares Short Prior Month
926 720
200 Day MA
17.58 USD
Short Ratio
20.6
Shares Short
952 350
Short Percent
–
BeatStart